Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data
British Journal of General Practice · 2023
DOI: 10.3399/bjgp.2023.0023 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift British Journal of General Practice, 2023. Verfasst von Jalen Brown und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, US. Hauptthemen laut MEDLINE: HIV Infections, Neoplasms, Transgender Persons. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Transgender and gender diverse (TGD) individuals experience an incongruence between their assigned birth sex and gender identity. They may have a higher prevalence of health conditions associated with cancer risk than cisgender people.
Aim
To examine the prevalence of several cancer risk factors among TGD individuals compared with cisgender individuals. Design and setting A cross-sectional analysis was conducted using data from the UKs Clinical Practice Research Datalink to identify TGD individuals between 19882020, matched to 20 cisgender men and 20 cisgender women on index date (date of diagnosis with gender incongruence), practice, and index age (age at index date). Assigned birth sex was determined from gender-affirming hormone use and procedures, and sex-specific diagnoses documented in the medical record.
Method
The prevalence of each cancer risk factor was calculated and the prevalence ratio by gender identity was estimated using log binomial or Poisson regression models adjusted for age and year at study entry, and obesity where appropriate.
Results
There were 3474 transfeminine (assigned male at birth) individuals, 3591 transmasculine (assigned female at birth) individuals, 131 747 cisgender men, and 131 827 cisgender women. Transmasculine people had the highest prevalence of obesity (27.5%) and ever smoking (60.2%). Transfeminine people had the highest prevalence of dyslipidaemia (15.1%), diabetes (5.4%), hepatitis C infection (0.7%), hepatitis B infection (0.4%), and HIV infection (0.8%). These prevalence estimates remained elevated in the TGD populations compared with cisgender persons in the multivariable models.
Conclusion
Multiple cancer risk factors are more prevalent among TGD individuals compared with cisgender individuals. Future research should examine how minority stress contributes to the increased prevalence of cancer risk factors in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, US.
- Department of Medical Education, Brighton and Sussex Medical School, Brighton, UK.
- Live Through This Charity, London, UK.
- Barts Cancer Institute, Queen Mary University of London, London, UK; Gender Identity Clinic, Tavistock and Portman NHS Foundation Trust, London, UK.
ORCID-Profile: Ruth M Pfeiffer, Duncan Shrewsbury, Alison M Berner, Shahinaz M Gadalla, Meredith S Shiels, Sarah S Jackson
Zitieren
APA
Brown, J., Pfeiffer, R. M., Shrewsbury, D., O'Callaghan, S., Berner, A. M., Gadalla, S. M., Shiels, M. S., & Jackson, S. S. (2023). Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data. British Journal of General Practice. https://doi.org/10.3399/bjgp.2023.0023
Vancouver
Brown J, Pfeiffer RM, Shrewsbury D, O'Callaghan S, Berner AM, Gadalla SM, et al. Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data. British Journal of General Practice. 2023. doi:10.3399/bjgp.2023.0023
BibTeX
@article{Brown2023,
author = {Brown, Jalen and Pfeiffer, Ruth M and Shrewsbury, Duncan and O'Callaghan, Stewart and Berner, Alison M and Gadalla, Shahinaz M and Shiels, Meredith S and Jackson, Sarah S},
title = {Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data},
journal = {British Journal of General Practice},
year = {2023},
doi = {10.3399/bjgp.2023.0023}
}
EUVIMED